Is the expression of &gamma;-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Mar 15, 2003; 9(3): 468-473
Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.468

Table 7 Significant factors in recurrence and death

Parameters	Recurrence		Death
Parameters	UV	MV	UV	MV
Sex	n.s.	n.s.	n.s.	n.s.
Age	n.s.	n.s.	n.s.	n.s.
Child-Pugh’s classification: A vs. B	n.s.	n.s.	n.s.	n.s.
HBsAg (+)	n.s.	n.s.	0.0166	n.s.
HCV (+)	n.s.	n.s.	n.s.	n.s.
AFP < 20 vs. 20-1000	0.0001	0.0108	0.0006	0.0141
γ-GTP mRNA (+)	n.s.	n.s.	n.s.	n.s.
Pathology of HCC:
Size: <3 cm vs. 3-10 cm	0.0213	n.s.	0.0080	n.s.
Cirrhosis	n.s.	n.s.	n.s.	n.s.
Edmondson-Steiner grade	0.0001	n.s.	0.0007	n.s.
Complete capsule (+)	< 0.0001	0.0084	< 0.0001	0.0130
Vascular permeation (+)	0.0003	n.s.	0.0001	0.0053
Daughter nodules (+)	0.0549	n.s.	0.0550	n.s.
Multicentric (+)	0.0094	n.s.	0.0119	n.s.
Type B γ-GTP mRNA in HCC liver	0.0003	0.0107	0.0046	n.s.
Type B γ-GTP mRNA in non-HCC liver	0.0001	n.s.	0.0007	n.s.

Denotes: n.s. = not significant.

Citation: Sheen IS, Jeng KS, Tsai YC. Is the expression of γ-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma? World J Gastroenterol 2003; 9(3): 468-473
URL: https://www.wjgnet.com/1007-9327/full/v9/i3/468.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i3.468

Sheen IS, Jeng KS, Tsai YC. Is the expression of γ-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma? World J Gastroenterol 2003; 9(3): 468-473 [PMID: 12632499 DOI: 10.3748/wjg.v9.i3.468]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.